DRL Q2 PAT seen down 6% to Rs 270 cr YoY

Dr Reddy's Labs (DRL) is expected to report a profit after tax of Rs 270 crore for the second quarter of FY12, a fall of 6% as compared to Rs 286.8 crore in the corresponding quarter of last fiscal, as per IFRS.

Revenues are seen going up by 12% to Rs 2,096 crore from Rs 1,870 crore and EBITDA too is likely to go up by 20% to Rs 387 crore from Rs 323 crore year-on-year.
Operating profit margin is seen improving at 18% in the July-September quarter of FY12 as against 17.3% in same quarter the previous year and 14% in the previous quarter.
On quarter-on-quarter basis, DRL's revenues are expected to jump 6% and EBITDA to rise by 38%. Profit after tax is likely to increase 2.5%.
One should watch out for forex (gain/loss) in September quarter.